ZA923516B - New thiopyranopyrrole derivatives and their preparation - Google Patents
New thiopyranopyrrole derivatives and their preparationInfo
- Publication number
- ZA923516B ZA923516B ZA923516A ZA923516A ZA923516B ZA 923516 B ZA923516 B ZA 923516B ZA 923516 A ZA923516 A ZA 923516A ZA 923516 A ZA923516 A ZA 923516A ZA 923516 B ZA923516 B ZA 923516B
- Authority
- ZA
- South Africa
- Prior art keywords
- preparation
- thiopyranopyrrole derivatives
- new
- derivatives
- new thiopyranopyrrole
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9106038A FR2676447B1 (fr) | 1991-05-17 | 1991-05-17 | Nouveaux derives du thiopyranopyrrole et leur preparation. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA923516B true ZA923516B (en) | 1993-02-24 |
Family
ID=9412910
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA923516A ZA923516B (en) | 1991-05-17 | 1992-05-14 | New thiopyranopyrrole derivatives and their preparation |
Country Status (18)
Country | Link |
---|---|
US (1) | US5484942A (xx) |
EP (2) | EP0514276A1 (xx) |
JP (1) | JPH06507895A (xx) |
AU (1) | AU653032B2 (xx) |
CA (1) | CA2109295A1 (xx) |
CZ (1) | CZ245093A3 (xx) |
FI (1) | FI935074A (xx) |
FR (1) | FR2676447B1 (xx) |
HU (1) | HUT65590A (xx) |
IE (1) | IE921544A1 (xx) |
IL (1) | IL101865A0 (xx) |
MX (1) | MX9202290A (xx) |
NO (1) | NO933690D0 (xx) |
NZ (1) | NZ242738A (xx) |
SK (1) | SK126693A3 (xx) |
WO (1) | WO1992020686A1 (xx) |
YU (1) | YU51092A (xx) |
ZA (1) | ZA923516B (xx) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2676446B1 (fr) * | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent. |
FR2728166A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Composition topique contenant un antagoniste de substance p |
FR2728165A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene |
FR2728169A1 (fr) | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales |
FR2741262B1 (fr) | 1995-11-20 | 1999-03-05 | Oreal | Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene |
CN1414953A (zh) | 1999-11-03 | 2003-04-30 | 阿尔巴尼分子研究公司 | 芳基和杂芳基取代的四氢异喹啉及其阻断去甲肾上腺素、多巴胺和5-羟色胺重摄取的用途 |
US7163949B1 (en) | 1999-11-03 | 2007-01-16 | Amr Technology, Inc. | 4-phenyl substituted tetrahydroisoquinolines and use thereof |
AU7334901A (en) | 2000-07-11 | 2002-01-21 | Du Pont Pharm Co | Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof |
MX2007000428A (es) | 2004-07-15 | 2008-03-05 | Amr Technology Inc | Tetrahidroisoquinolinas sustituidas con arilo y heteroarilo y uso de las mismas para bloquear la captacion de norepinefrina, dopamina y serotonina. |
ATE550019T1 (de) | 2005-05-17 | 2012-04-15 | Merck Sharp & Dohme | Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs |
CA2615403C (en) | 2005-07-15 | 2015-06-16 | Amr Technology, Inc. | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
EP2109608B1 (en) | 2007-01-10 | 2011-03-23 | Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. | Amide substituted indazoles as poly(adp-ribose)polymerase (parp) inhibitors |
JP5501227B2 (ja) | 2007-06-27 | 2014-05-21 | メルク・シャープ・アンド・ドーム・コーポレーション | ヒストンデアセチラーゼ阻害剤としての4−カルボキシベンジルアミノ誘導体 |
AR071997A1 (es) | 2008-06-04 | 2010-07-28 | Bristol Myers Squibb Co | Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina |
US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
EP2413932A4 (en) | 2009-04-01 | 2012-09-19 | Merck Sharp & Dohme | INHIBITORS OF AKT ACTIVITY |
ES2662072T3 (es) | 2009-05-12 | 2018-04-05 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y uso de la misma |
KR20120034644A (ko) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | 아릴, 헤테로아릴, 및 헤테로사이클 치환된 테트라하이드로이소퀴놀린 및 이의 용도 |
EP2429293B1 (en) | 2009-05-12 | 2014-10-29 | Bristol-Myers Squibb Company | CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF |
KR101485645B1 (ko) | 2009-10-14 | 2015-01-22 | 머크 샤프 앤드 돔 코포레이션 | p53 활성을 증가시키는 치환된 피페리딘 및 그의 용도 |
CN107090456B (zh) | 2010-08-02 | 2022-01-18 | 瑟纳治疗公司 | 使用短干扰核酸的RNA干扰介导的联蛋白(钙粘蛋白关联蛋白质),β1基因表达的抑制 |
HUE044815T2 (hu) | 2010-08-17 | 2019-11-28 | Sirna Therapeutics Inc | Hepatitisz B vírus (HBV) génexpressziójának RNS-interferencia közvetített gátlása, rövid interferáló nukleinsav (SINS) alkalmazásával |
US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
WO2012030685A2 (en) | 2010-09-01 | 2012-03-08 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
US9242981B2 (en) | 2010-09-16 | 2016-01-26 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel ERK inhibitors |
WO2012058210A1 (en) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA) |
US9351965B2 (en) | 2010-12-21 | 2016-05-31 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
CN103732592A (zh) | 2011-04-21 | 2014-04-16 | 默沙东公司 | 胰岛素样生长因子-1受体抑制剂 |
US9023865B2 (en) | 2011-10-27 | 2015-05-05 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
EP3919620A1 (en) | 2012-05-02 | 2021-12-08 | Sirna Therapeutics, Inc. | Short interfering nucleic acid (sina) compositions |
CA2882950A1 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
LT2925888T (lt) | 2012-11-28 | 2018-01-10 | Merck Sharp & Dohme Corp. | Vėžio gydymo kompozicijos ir būdai |
BR112015013611A2 (pt) | 2012-12-20 | 2017-11-14 | Merck Sharp & Dohme | composto, e, composição farmacêutica |
WO2014120748A1 (en) | 2013-01-30 | 2014-08-07 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as hdm2 inhibitors |
US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
US20210309688A1 (en) | 2018-08-07 | 2021-10-07 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
US20210277009A1 (en) | 2018-08-07 | 2021-09-09 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4042707A (en) * | 1976-02-19 | 1977-08-16 | E. I. Du Pont De Nemours And Company | 3α-Arylhydroisoindoles |
AU502760B2 (en) * | 1977-02-28 | 1979-08-09 | Science Union Et Cie, Societe Francaise De Recherche Medicale | Azabicycloalkanes and their preparation |
DE3276311D1 (en) * | 1981-02-17 | 1987-06-19 | Warner Lambert Co | Octahydro-2-(omega-mercaptoalkanoyl)3-oxo-1h-isoindole-1-carboxylic acids and esters |
US4439229A (en) * | 1981-06-29 | 1984-03-27 | Rohm And Haas Company | Substituted phthalimides herbicides |
US4503043A (en) * | 1981-12-07 | 1985-03-05 | Warner-Lambert Company | Substituted acyl derivatives of octahydro-1H-isoindole-1-carboxylic acids |
JPH0278659A (ja) * | 1988-09-12 | 1990-03-19 | Shionogi & Co Ltd | アザビシクロアルカン類化合物 |
FR2676446B1 (fr) * | 1991-05-17 | 1993-08-06 | Rhone Poulenc Rorer Sa | Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent. |
-
1991
- 1991-05-17 FR FR9106038A patent/FR2676447B1/fr not_active Expired - Lifetime
-
1992
- 1992-05-14 YU YU51092A patent/YU51092A/sh unknown
- 1992-05-14 NZ NZ24273892A patent/NZ242738A/en unknown
- 1992-05-14 ZA ZA923516A patent/ZA923516B/xx unknown
- 1992-05-14 IL IL101865A patent/IL101865A0/xx unknown
- 1992-05-15 US US08/146,144 patent/US5484942A/en not_active Expired - Fee Related
- 1992-05-15 WO PCT/FR1992/000432 patent/WO1992020686A1/fr not_active Application Discontinuation
- 1992-05-15 AU AU19137/92A patent/AU653032B2/en not_active Ceased
- 1992-05-15 EP EP92401332A patent/EP0514276A1/fr active Pending
- 1992-05-15 JP JP4511263A patent/JPH06507895A/ja active Pending
- 1992-05-15 HU HU9303251A patent/HUT65590A/hu unknown
- 1992-05-15 EP EP92911607A patent/EP0587673A1/fr not_active Ceased
- 1992-05-15 CZ CS932450A patent/CZ245093A3/cs unknown
- 1992-05-15 MX MX9202290A patent/MX9202290A/es not_active IP Right Cessation
- 1992-05-15 CA CA002109295A patent/CA2109295A1/fr not_active Abandoned
- 1992-05-15 SK SK1266-93A patent/SK126693A3/sk unknown
- 1992-07-01 IE IE154492A patent/IE921544A1/en not_active Application Discontinuation
-
1993
- 1993-10-13 NO NO1993933690A patent/NO933690D0/no unknown
- 1993-11-16 FI FI935074A patent/FI935074A/fi unknown
Also Published As
Publication number | Publication date |
---|---|
CA2109295A1 (fr) | 1992-11-18 |
AU653032B2 (en) | 1994-09-15 |
EP0514276A1 (fr) | 1992-11-19 |
JPH06507895A (ja) | 1994-09-08 |
MX9202290A (es) | 1993-02-01 |
AU1913792A (en) | 1992-12-30 |
NZ242738A (en) | 1994-07-26 |
IE921544A1 (en) | 1992-11-18 |
HU9303251D0 (en) | 1994-03-28 |
WO1992020686A1 (fr) | 1992-11-26 |
EP0587673A1 (fr) | 1994-03-23 |
HUT65590A (en) | 1994-07-28 |
US5484942A (en) | 1996-01-16 |
FR2676447A1 (fr) | 1992-11-20 |
SK126693A3 (en) | 1994-05-11 |
NO933690L (no) | 1993-10-13 |
FI935074A0 (fi) | 1993-11-16 |
FI935074A (fi) | 1993-11-16 |
YU51092A (sh) | 1994-06-10 |
CZ245093A3 (en) | 1994-03-16 |
NO933690D0 (no) | 1993-10-13 |
FR2676447B1 (fr) | 1993-08-06 |
IL101865A0 (en) | 1992-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA923516B (en) | New thiopyranopyrrole derivatives and their preparation | |
GR3023258T3 (en) | 3-Aryl-4-hydroxy-delta3-dihydrofuranone and 3-aryl-4-hydroxy-delta3-dihydrothiophenone derivatives | |
IL118825A (en) | Substituted 6-dimethylaminomethyl-1-phenyl-cyclohexane derivatives their preparation and use | |
NZ239476A (en) | 3-amidopyrazole derivatives; medicaments and preparation thereof | |
IL114795A0 (en) | N-benzylindole- and benmzopyrazole derivatives their preparation and use | |
EP0498268A3 (en) | 5-oxo-l-proline derivatives and pharmaceutical use thereof | |
IL101222A0 (en) | Cyclohexanetriol derivatives and their preparation | |
ZA921279B (en) | Substituted alpha-aminoaldehydes and derivatives | |
EP0482649A3 (en) | Cm-chitin derivatives and use thereof | |
ZA926189B (en) | Beta-Phenylisoserine derivatives and their preparation and use. | |
ZA929770B (en) | Heterocyclic compounds and their preparation and use | |
EG21121A (en) | 13 Substituted milbemycin derivatives their preparation and use | |
GB9116896D0 (en) | 3-deoxymannosamine derivatives and process for their preparation | |
GB9120628D0 (en) | Pyrrolobenzoxazine derivatives and process for preparation thereof | |
ZA943649B (en) | Piperidine derivatives their preparation and use | |
ZA912630B (en) | New ethylene-substituted phenylalkylethylenediamine-platinum(ii or iv)derivatives and phenylalkylethylenediamines | |
IL102467A0 (en) | Substituted pyridines and their preparation | |
GB9027864D0 (en) | Pyrimidinyl-and triazinyl-salicylamides and their use and preparation | |
HUT66140A (en) | New 2-spirocyclopropyl-cephalosporin-sulfone derivatives and process for the preparation thereof | |
IL102539A0 (en) | Preparation of 17beta-substituted-4-aza 5alpha-androstan-3-one derivatives | |
ZA925791B (en) | Quartromicin and its derivatives and salts | |
ZA924038B (en) | New oxazole derivatives and their preparation and use | |
IL97859A0 (en) | 1,5-benzothiazepinone derivatives,their preparation and pharmaceutical use | |
AU2500992A (en) | Quinazoline derivatives and their preparation | |
IL99212A0 (en) | Cyclohexenol derivatives and their preparation |